PMV Pharmaceuticals Inc (PMVP)
1.62
+0.01
(+0.62%)
USD |
NASDAQ |
Apr 18, 16:00
1.625
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Shareholders Equity (Quarterly): 225.69M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 225.69M |
| September 30, 2023 | 237.61M |
| June 30, 2023 | 217.81M |
| March 31, 2023 | 230.17M |
| December 31, 2022 | 246.03M |
| September 30, 2022 | 261.19M |
| June 30, 2022 | 276.97M |
| March 31, 2022 | 291.84M |
| Date | Value |
|---|---|
| December 31, 2021 | 308.56M |
| September 30, 2021 | 324.95M |
| June 30, 2021 | 337.85M |
| March 31, 2021 | 348.30M |
| December 31, 2020 | 359.12M |
| September 30, 2020 | 368.97M |
| June 30, 2020 | 153.90M |
| December 31, 2019 | -70.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-70.47M
Minimum
Dec 2019
368.97M
Maximum
Sep 2020
257.40M
Average
269.08M
Median
Shareholders Equity (Quarterly) Benchmarks
| Exelixis Inc | 2.264B |
| Geron Corp | 247.95M |
| Verastem Inc | 57.37M |
| Karyopharm Therapeutics Inc | -136.21M |
| Kura Oncology Inc | 397.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.15M |
| Total Liabilities (Quarterly) | 26.46M |